NASDAQ: NAOV - NanoVibronix, Inc.

Rentabilité sur six mois: -44%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions NanoVibronix, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise NanoVibronix, Inc.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

plus de détails
The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2017-06-27
ISIN US63008J1088
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nanovibronix.com
Цена ао 3.89
Changement de prix par jour: -3.58% (3.91)
Changement de prix par semaine: -14.12% (4.39)
Changement de prix par mois: +5.42% (3.5761)
Changement de prix sur 3 mois: -40.93% (6.3822)
Changement de prix sur six mois: -44% (6.732)
Changement de prix par an: +318.89% (0.9)
Evolution du prix sur 3 ans: +314.51% (0.9095)
Evolution du prix sur 5 ans: +35.74% (2.7774)
Evolution des prix depuis le début de l'année: +604.41% (0.5352)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0.7896 9
P/BV 0.452 10
P/E 0 0
EV/EBITDA 0.4295 10
Total: 6.13

Efficacité

Nom Signification Grade
ROA, % -55.6 0
ROE, % -93.05 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.0015 10
Total: 9.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 330.75 10
Rentabilité Ebitda, % -38.66 0
Rentabilité EPS, % -87.3 0
Total: 2
Plus de détails

Établissements Volume Partager, %
Renaissance Technologies, LLC 41200 1.48
Vanguard Group Inc 30194 1.08
Geode Capital Management, LLC 14461 0.52
Amtrust Financial Services, Inc. 12408 0.45
Tower Research Capital LLC (TRC) 5262 0.19
UBS Group AG 3537 0.13
National Bank of Canada/FI 110 0
Blackrock Inc. 74 0
Wells Fargo & Company 13 0
Morgan Stanley 10 0



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Brian M. Murphy CEO & Director 382.5k 1957 (68 années)
Mr. Stephen R. Brown CPA Chief Financial Officer 292.5k 1956 (69 années)
Dr. Harold Jacob M.D. Chief Medical Officer & Director N/A 1954 (71 année)
Mr. Amir Rippel Vice President of Marketing N/A
Ms. Lindsey Harrison Vice President of Sales N/A

Adresse: United States, Elmsford. NY, 525 Executive Boulevard - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nanovibronix.com